Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
First Edition BOGP (0)
United Kingdom (3)
Research
Neurology/Parkinson's Disease (1)
Insurance Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase II